Clinical Trial Update: Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

View source ↗

Summary

Follow-up results show the persistence of protective antibody titers 12-24 months after NmVac4-A/C/Y/W-135-DT vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infection
• Meningococcal Meningitis

Drugs mentioned

• NmVac4-A/C/Y/W-135-DT

Snippet

Sponsor: JN-International Medical Corporation | Conditions: Meningococcal Meningitis, Meningococcal Infections | Status: COMPLETED